Consultant interview - Mr Daniel Sibley

Please tell us more about your areas of expertise.

Within my corneal speciality, I have a specialist interest in treating ocular surface inflammatory conditions in adults including blepharitis, Steven-Johnson Syndrome (SJS), pemphigoid, as well as chemical injuries of the cornea and limbal stem cell deficiency (LSCD). I have completed a fellowship training in the management of these conditions, including ocular surface reconstruction with different types of corneal transplantation (graft) and limbal stem cell transplantation.

I am a member of European, UK and Ireland societies for cataract and refractive surgeons. My dual corneal and refractive expertise would be especially beneficial for patients with thin or unusual corneas who are referred for cataract or who consider vision correction.

Why do patients come to see you?

I see a lot of corneal patients who come to my clinic at Moorfields Private from all over the UK as well from abroad. They usually present with ocular pain, severe eye dryness and inflammation which isn’t resolved with over-the-counter medication or with treatments available to them in the primary care. Some patients get referred to my clinic after being seen in the A&E setting or at their community optometry practice. Other patients refer themselves for a second opinion being concerned their chronic ocular inflammatory symptoms are not getting better affecting the quality of their live and their vision. 

Please tell us about your recent research projects.

I am interested in complex ocular surface research such as the first human intragenic stem cell study led by Professor Sajjad Ahmad in association with UCL Institute of Ophthalmology that I also was fortunate to contribute to. The focus of that study was on developing a novel stem cell therapy for the treatment of patients with aniridia PAX6 gene mutation.